Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
34.42 M
About INTELLIPHARMACEUTICS INTL INC
Sector
CEO
Isa Odidi
Headquarters
Toronto
Website
Founded
1998
FIGI
BBG000C0S7F3
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IPCIF is 0.000001 USD — it hasn't changed in the past 24 hours. Watch Intellipharmaceutics International Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Intellipharmaceutics International Inc. stocks are traded under the ticker IPCIF.
IPCIF reached its all-time high on Mar 3, 2000 with the price of 198,863.634375 USD, and its all-time low was 0.000001 USD and was reached on Jul 5, 2024. View more price dynamics on IPCIF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IPCIF stock is 0.00% volatile and has beta coefficient of 1.69. Track Intellipharmaceutics International Inc. stock price on the chart and check out the list of the most volatile stocks — is Intellipharmaceutics International Inc. there?
Today Intellipharmaceutics International Inc. has the market capitalization of 2.02 M, it has decreased by −0.28% over the last week.
Yes, you can track Intellipharmaceutics International Inc. financials in yearly and quarterly reports right on TradingView.
Intellipharmaceutics International Inc. is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
No, IPCIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IPCIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Intellipharmaceutics International Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Intellipharmaceutics International Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Intellipharmaceutics International Inc. stock shows the sell signal. See more of Intellipharmaceutics International Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.